JP2022526659A5 - - Google Patents

Info

Publication number
JP2022526659A5
JP2022526659A5 JP2021559890A JP2021559890A JP2022526659A5 JP 2022526659 A5 JP2022526659 A5 JP 2022526659A5 JP 2021559890 A JP2021559890 A JP 2021559890A JP 2021559890 A JP2021559890 A JP 2021559890A JP 2022526659 A5 JP2022526659 A5 JP 2022526659A5
Authority
JP
Japan
Prior art keywords
compound
formula
acid
reacted
obtain compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021559890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526659A (ja
JP7631218B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/027655 external-priority patent/WO2020210613A1/en
Publication of JP2022526659A publication Critical patent/JP2022526659A/ja
Publication of JP2022526659A5 publication Critical patent/JP2022526659A5/ja
Priority to JP2025017468A priority Critical patent/JP7885383B2/ja
Application granted granted Critical
Publication of JP7631218B2 publication Critical patent/JP7631218B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021559890A 2019-04-11 2020-04-10 (6r,10s)-10-{4-[5-クロロ-2-(4-クロロ-1h-1,2,3-トリアゾール-1-イル)フェニル]-6-オキソ-1(6h)-ピリミジニル}-1-(ジフルオロメチル)-6-メチル-1,4,7,8,9,10-ヘキサヒドロ-11,15-(メタノ)ピラゾロ[4,3-b][1,7]ジアザシクロテトラデシン-5(6h)-オンの製造における新規合成法 Active JP7631218B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025017468A JP7885383B2 (ja) 2019-04-11 2025-02-05 (6r,10s)-10-{4-[5-クロロ-2-(4-クロロ-1h-1,2,3-トリアゾール-1-イル)フェニル]-6-オキソ-1(6h)-ピリミジニル}-1-(ジフルオロメチル)-6-メチル-1,4,7,8,9,10-ヘキサヒドロ-11,15-(メタノ)ピラゾロ[4,3-b][1,7]ジアザシクロテトラデシン-5(6h)-オンの製造における新規合成法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962832614P 2019-04-11 2019-04-11
US62/832,614 2019-04-11
PCT/US2020/027655 WO2020210613A1 (en) 2019-04-11 2020-04-10 Novel synthetic options towards the manufacture of (6r,10s)-10- {4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)- pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15 -(metheno)pyrazolo [4,3-b] [1,7] diazacyclotetradecin-5(6h)-one

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025017468A Division JP7885383B2 (ja) 2019-04-11 2025-02-05 (6r,10s)-10-{4-[5-クロロ-2-(4-クロロ-1h-1,2,3-トリアゾール-1-イル)フェニル]-6-オキソ-1(6h)-ピリミジニル}-1-(ジフルオロメチル)-6-メチル-1,4,7,8,9,10-ヘキサヒドロ-11,15-(メタノ)ピラゾロ[4,3-b][1,7]ジアザシクロテトラデシン-5(6h)-オンの製造における新規合成法

Publications (3)

Publication Number Publication Date
JP2022526659A JP2022526659A (ja) 2022-05-25
JP2022526659A5 true JP2022526659A5 (cg-RX-API-DMAC7.html) 2023-04-12
JP7631218B2 JP7631218B2 (ja) 2025-02-18

Family

ID=70457148

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021559890A Active JP7631218B2 (ja) 2019-04-11 2020-04-10 (6r,10s)-10-{4-[5-クロロ-2-(4-クロロ-1h-1,2,3-トリアゾール-1-イル)フェニル]-6-オキソ-1(6h)-ピリミジニル}-1-(ジフルオロメチル)-6-メチル-1,4,7,8,9,10-ヘキサヒドロ-11,15-(メタノ)ピラゾロ[4,3-b][1,7]ジアザシクロテトラデシン-5(6h)-オンの製造における新規合成法
JP2025017468A Active JP7885383B2 (ja) 2019-04-11 2025-02-05 (6r,10s)-10-{4-[5-クロロ-2-(4-クロロ-1h-1,2,3-トリアゾール-1-イル)フェニル]-6-オキソ-1(6h)-ピリミジニル}-1-(ジフルオロメチル)-6-メチル-1,4,7,8,9,10-ヘキサヒドロ-11,15-(メタノ)ピラゾロ[4,3-b][1,7]ジアザシクロテトラデシン-5(6h)-オンの製造における新規合成法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025017468A Active JP7885383B2 (ja) 2019-04-11 2025-02-05 (6r,10s)-10-{4-[5-クロロ-2-(4-クロロ-1h-1,2,3-トリアゾール-1-イル)フェニル]-6-オキソ-1(6h)-ピリミジニル}-1-(ジフルオロメチル)-6-メチル-1,4,7,8,9,10-ヘキサヒドロ-11,15-(メタノ)ピラゾロ[4,3-b][1,7]ジアザシクロテトラデシン-5(6h)-オンの製造における新規合成法

Country Status (16)

Country Link
US (2) US12378246B2 (cg-RX-API-DMAC7.html)
EP (2) EP4234555A3 (cg-RX-API-DMAC7.html)
JP (2) JP7631218B2 (cg-RX-API-DMAC7.html)
KR (2) KR20260047658A (cg-RX-API-DMAC7.html)
CN (2) CN114375290B (cg-RX-API-DMAC7.html)
AR (1) AR118649A1 (cg-RX-API-DMAC7.html)
AU (2) AU2020272973B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021020368A2 (cg-RX-API-DMAC7.html)
CA (1) CA3132365A1 (cg-RX-API-DMAC7.html)
EA (1) EA202192807A1 (cg-RX-API-DMAC7.html)
ES (1) ES2969253T3 (cg-RX-API-DMAC7.html)
IL (1) IL287102B2 (cg-RX-API-DMAC7.html)
MX (2) MX2025014306A (cg-RX-API-DMAC7.html)
SG (1) SG11202111132WA (cg-RX-API-DMAC7.html)
TW (1) TWI880924B (cg-RX-API-DMAC7.html)
WO (1) WO2020210613A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11788071B2 (en) 2020-04-10 2023-10-17 Codexis, Inc. Engineered transaminase polypeptides
EP4225757A1 (en) * 2020-10-12 2023-08-16 Bristol-Myers Squibb Company A process toward the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}-1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b] [1,7]diazacyclotetradecin-5(6h)-one

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013033777A2 (pt) * 2011-03-15 2016-09-13 Abbvie Inc moduladores de receptor de hormônio nuclear
JP6505727B2 (ja) 2014-01-31 2019-04-24 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company ヘテロ環式p2’基を有する第xia因子阻害剤としてのマクロ環
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
NO2721243T3 (cg-RX-API-DMAC7.html) * 2014-10-01 2018-10-20
CN105294496A (zh) 2015-09-28 2016-02-03 中山大学 一种西酞普兰中间体的制备方法
CN110062757B (zh) 2017-01-18 2022-03-04 广东东阳光药业有限公司 凝血因子XIa抑制剂及其用途
CN113677682B (zh) 2019-04-16 2023-05-30 华润生物医药有限公司 作为XIa因子抑制剂的大环衍生物
WO2021013209A1 (zh) 2019-07-23 2021-01-28 南京明德新药研发有限公司 作为XIa因子抑制剂的大环衍生物
CA3179679A1 (en) 2020-04-10 2021-10-14 Codexis, Inc. Carboxyesterase polypeptides for kinetic resolution

Similar Documents

Publication Publication Date Title
AU778596B2 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives
JP2001515084A5 (cg-RX-API-DMAC7.html)
JP2005525422A5 (ja) Pmeaおよびpmpa環生成合成
RU2010126906A (ru) Способ получения производного индолинона
JP2010521464A5 (cg-RX-API-DMAC7.html)
JP2021503470A5 (cg-RX-API-DMAC7.html)
JP2013515761A (ja) タペンタドールおよび関連化合物の調製のための中間体化合物とプロセス
RU2011103997A (ru) Способ получения производных r-бета-аминофенилмасляной кислоты
EP3301087A1 (en) Process for preparing chiral amines
JP2003313184A5 (cg-RX-API-DMAC7.html)
FR2636625A1 (fr) Benzylamines disubstituees, leur procede de preparation, leur utilisation comme medicament et leurs intermediaires de synthese
EP1720823B1 (en) New process for the synthesis of substituted alpha-aminoidan derivatives
US8076503B2 (en) Process for production of optically active aminophosphinylbutanoic acids
JP2002516313A5 (cg-RX-API-DMAC7.html)
JP5555919B2 (ja) 新規なスルホニウム塩、その製造方法及びその用途
JP2005526795A5 (cg-RX-API-DMAC7.html)
FR2915995A1 (fr) Ligands chiraux de type carbenes n-heterocycliques pour la catalyse asymetrique.
CA2116464C (en) Process for the preparation of an optically pure aminoalcohol
WO2005092830A1 (ja) 光学活性遷移金属-ジアミン錯体及びこれを用いた光学活性アルコール類の製造方法
US20050272930A1 (en) Process for the prepation of 3-hydroxy-(2-thienyl)propanamines
DE68906372T2 (de) Verfahren zur herstellung von optisch aktiven threo-dihydroxyphenylserine-derivaten.
RU98103460A (ru) Производные бензолсульфонамида, их получение и терапевтическое применение
US6881845B2 (en) Process for preparing (±)trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
Dalmolen et al. Synthesis of Enantiopure 1‐Aryl‐1‐butylamines and 1‐Aryl‐3‐butenylamines by Diastereoselective Addition of Allylzinc Bromide to Imines Derived from (R)‐Phenylglycine Amide
CN1989097A (zh) 用于制备非对映异构体富集的化合物的方法